Filing Details
- Accession Number:
- 0000914190-18-000139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-12 16:12:50
- Reporting Period:
- 2018-04-10
- Accepted Time:
- 2018-04-12 16:12:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1196298 | Nephros Inc | NEPH | Surgical & Medical Instruments & Apparatus (3841) | 133971809 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1411726 | Daron Evans | C/O Nephros, Inc. 380 Lackawanna Place South Orange NJ 07079 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-04-10 | 55,000 | $0.45 | 55,000 | No | 4 | P | Indirect | By PoC Capital, LLC |
| Common Stock | Acquisiton | 2018-04-10 | 12,000 | $0.45 | 65,666 | No | 4 | P | Indirect | By UTMA #1 |
| Common Stock | Acquisiton | 2018-04-10 | 12,000 | $0.45 | 63,166 | No | 4 | P | Indirect | By UTMA #2 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By PoC Capital, LLC |
| No | 4 | P | Indirect | By UTMA #1 |
| No | 4 | P | Indirect | By UTMA #2 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 892,958 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $0.46 | 2024-03-26 | 75,361 | 75,361 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $0.60 | 2025-04-15 | 982,887 | 982,887 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $0.50 | 2027-12-20 | 837,125 | 837,125 | Direct | |
| Common Stock | Common Stock Warrants (Right to Buy) | $0.30 | 2016-06-03 | 2021-06-03 | 40,000 | 40,000 | Indirect |
| Common Stock | Common Stock Warrants (Right to Buy) | $0.30 | 2016-06-03 | 2021-06-03 | 10,000 | 10,000 | Indirect |
| Common Stock | Common Stock Warrants (Right to Buy) | $0.30 | 2016-06-03 | 2021-06-03 | 10,000 | 10,000 | Indirect |
| Common Stock | Common Stock Warrants (Right to Buy) | $0.30 | 2017-03-17 | 2022-03-17 | 41,666 | 41,666 | Indirect |
| Common Stock | Common Stock Warrants (Right to Buy) | $0.30 | 2017-03-17 | 2022-03-17 | 41,666 | 41,666 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-03-26 | 75,361 | 75,361 | Direct |
| 2025-04-15 | 982,887 | 982,887 | Direct |
| 2027-12-20 | 837,125 | 837,125 | Direct |
| 2021-06-03 | 40,000 | 40,000 | Indirect |
| 2021-06-03 | 10,000 | 10,000 | Indirect |
| 2021-06-03 | 10,000 | 10,000 | Indirect |
| 2022-03-17 | 41,666 | 41,666 | Indirect |
| 2022-03-17 | 41,666 | 41,666 | Indirect |
Footnotes
- Includes 180,000 shares of restricted stock that vest on 6/20/18.
- The Reporting Person is a managing director of the LLC that owns the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- Fully exercisable.
- On 4/15/2015, the Reporting Person was granted an option to purchase up to 2,184,193 shares of common stock of the Company. 35% of the shares subject to the option (relating to a total of 764,468 shares) vest quarterly in 16 equal amounts, commencing on 6/30/2015. 15% of the shares subject to the option will vest, if ever, upon the listing of the Company's common stock on NASDAQ, NYSE, or such other exchange as the Board may later determine. The remaining 50% of the shares subject to the option will vest, if ever, upon the Company's achievement of certain annual revenue milestones as specified in that certain Employment Agreement dated 4/15/2015 between the Reporting Person and the Company. The Company achieved the $3,000,000 annual revenue milestone in fiscal year 2017 and options to purchase 218,419 shares vested on 2/1/18.
- On 12/20/17, the Reporting Person was granted an option to purchase 837,125 shares of common stock of the Company. 25% of the shares subject to the option (relating to a total of 209,282 shares) vest on 12/20/18 and the remaining 75% of the shares subject to the option (relating to a total of 627,843 shares) vest quarterly in 12 equal amounts, commencing on 3/20/19.
Billionaire Hedge Funds
